The major human immunodeficiency virus type 2 (HIV-2) packaging signal is present on all HIV-2 RNA species: Cotranslational RNA encapsidation and limitation of Gag protein confer specificity

被引:77
作者
Griffin, SDC [1 ]
Allen, JF [1 ]
Lever, AML [1 ]
机构
[1] Univ Cambridge, Addenbrookes Hosp, Dept Med, Cambridge CB2 2QQ, England
关键词
D O I
10.1128/JVI.75.24.12058-12069.2001
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Deletion of a region of the human immunodeficiency virus type 2 (HIV-2) 5' leader RNA reduces genomic RNA encapsidation to about 5% that of wild-type virus with no defect in viral protein production but severely limits virus spread in Jurkat T cells, indicating that this region contains a major cis-acting encapsidation signal, or psi (psi). Being upstream of the major splice donor, it is present on all viral transcripts. We have shown that HIV-2 selects its genomic RNA for encapsidation cotranslationally, rendering wild-type HIV-2 unable to encapsidate vector RNAs in trans. Virus with psi deleted, however, encapsidates an HIV-2 vector, demonstrating competition for Gag protein. HIV-2 overcomes the lack of packaging signal location specificity by two novel mechanisms, cotranslational packaging and competition for limiting Gag polyprotein.
引用
收藏
页码:12058 / 12069
页数:12
相关论文
共 52 条
[21]   A CONSERVED CIS-ACTING SEQUENCE IN THE 5' LEADER OF AVIAN-SARCOMA VIRUS-RNA IS REQUIRED FOR PACKAGING [J].
KATZ, RA ;
TERRY, RW ;
SKALKA, AM .
JOURNAL OF VIROLOGY, 1986, 59 (01) :163-167
[22]   CIS-ACTING SEQUENCES INVOLVED IN HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 RNA PACKAGING [J].
KAYE, JF ;
RICHARDSON, JH ;
LEVER, AML .
JOURNAL OF VIROLOGY, 1995, 69 (10) :6588-6592
[23]   trans-Acting proteins involved in RNA encapsidation and viral assembly in human immunodeficiency virus type 1 [J].
Kaye, JF ;
Lever, AML .
JOURNAL OF VIROLOGY, 1996, 70 (02) :880-886
[24]   Nonreciprocal packaging of human immunodeficiency virus type 1 and type 2 RNA: a possible role for the p2 domain of Gag in RNA encapsidation [J].
Kaye, JF ;
Lever, AML .
JOURNAL OF VIROLOGY, 1998, 72 (07) :5877-5885
[25]   Human immunodeficiency virus types 1 and 2 differ in the predominant mechanism used for selection of genomic RNA for encapsidation [J].
Kaye, JF ;
Lever, AML .
JOURNAL OF VIROLOGY, 1999, 73 (04) :3023-3031
[26]   A SHORT SEQUENCE UPSTREAM OF THE 5' MAJOR SPLICE-SITE IS IMPORTANT FOR ENCAPSIDATION OF HIV-1 GENOMIC RNA [J].
KIM, HJ ;
LEE, K ;
OREAR, JJ .
VIROLOGY, 1994, 198 (01) :336-340
[27]   A BASE-PAIRED STRUCTURE IN THE AVIAN-SARCOMA VIRUS 5' LEADER IS REQUIRED FOR EFFICIENT ENCAPSIDATION OF RNA [J].
KNIGHT, JB ;
SI, ZH ;
STOLTZFUS, CM .
JOURNAL OF VIROLOGY, 1994, 68 (07) :4493-4502
[28]   CHARACTERIZATION OF A ROUS-SARCOMA VIRUS MUTANT DEFECTIVE IN PACKAGING ITS OWN GENOMIC RNA - BIOCHEMICAL-PROPERTIES OF MUTANT TK15 AND MUTANT-INDUCED TRANSFORMAANTS [J].
KOYAMA, T ;
HARADA, F ;
KAWAI, S .
JOURNAL OF VIROLOGY, 1984, 51 (01) :154-162
[29]  
KUNKEL TA, 1987, METHOD ENZYMOL, V154, P367
[30]   IDENTIFICATION OF A SEQUENCE REQUIRED FOR EFFICIENT PACKAGING OF HUMAN IMMUNODEFICIENCY VIRUS TYPE-1 RNA INTO VIRIONS [J].
LEVER, A ;
GOTTLINGER, H ;
HASELTINE, W ;
SODROSKI, J .
JOURNAL OF VIROLOGY, 1989, 63 (09) :4085-4087